POTELIGEO
- Product NDC
- 42747-761
- 11-digit product format
- 427470761
- Labeler code
- 42747
- Product ID
- 42747-761_2002b8eb-c6a6-4f3f-8a58-963fe6c015c4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mogamulizumab-kpkc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Kyowa Kirin, Inc.
- Application
- BLA761051
- Marketing category
- BLA
- Marketing start
- 2018-08-08
- Substance
- MOGAMULIZUMAB
- Active strength
- 4 mg/mL
- Pharmacologic classes
- Antibodies, Monoclonal [CS], Chemokine Receptor Type 4 Interaction [EPC], Chemokine Receptor Type 4 Interactions [MoA], Monoclonal Antibody [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- POTELIGEO
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MOGAMULIZUMAB | 4 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YI437801BE |
| Rxcui | 2054081, 2054086 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42747-761-01 | POTELIGEO | 1 in 1 CARTON | INJECTION | 1 | | 20 |
| 42747-761-01 | POTELIGEO | 5 mL in 1 VIAL, GLASS | INJECTION | 5 | | 20 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42747-761 | POTELIGEO (MOGAMULIZUMAB-KPKC) INJECTION [KYOWA KIRIN, INC.] | 18 | Current NDC, Legacy NDC, 2 package rows | 20250508_e53960ab-42a1-40d1-9c7d-eb013fe7f18f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42747-761-01 | 42747076101 | 1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS | 2018-08-08 | 0000-00-00 | No | No | Current |